136
Views
62
CrossRef citations to date
0
Altmetric
SUPPLEMENT: HEALTH BENEFITS OF CONJUGATED LINOLEIC ACID (CLA)

Conjugated Linoleic Acid and Bone Biology

, PhD, FACN & , PhD
Pages 478S-486S | Received 01 Feb 2000, Published online: 14 Jun 2013

REFERENCES

  • Baron R: Anatomy and ultrastructure of bone. In Favus MJ: “Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,” 2nd ed. New York: Raven Press, pp 3–9, 1993.
  • Baylink DJ, Finkelman RD, Mohan S: Growth factors to stimulate bone formation. J Bone Miner Res 8: S565–S572, 1993.
  • Mundy GR: Cytokines and growth factors in the regulation of bone remodeling. J Bone Miner Res 8: S505–S510, 1993.
  • Raisz LG: Bone cell biology: new approaches and unanswered questions. J Bone Miner Res 8: S457–S465, 1993.
  • Canalis B: Regulation of bone remodeling. In Favus MJ: “Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,” 2nd ed. New York: Raven Press, pp 33–37, 1993.
  • Blair HC, Schlesinger PH, Ross FP, Teitelbaum SL: Recent advances toward understanding osteoclast physiology. Clin Orthop 294: 7–22, 1993.
  • Frost HM: “Bone Remodeling and its Relationship to Metabolic Bone Disease.” Springfield, IL: Thomas, pp 28–53, 1993.
  • Frost HM: “Bone Remodeling Dynamics.” Springfield, IL: Thomas, 1963.
  • Kanis JA (ed): “Vol 4: Calcium Metabolism.” In Parfitt AM (ed): “Progress in Basic and Clinical Pharmacology.” Basel: Karger, pp 1–27, 1990.
  • Watrous DA, Andrews BS: The metabolism and immunology of bone. Semin Arthritis Rheum 19: 45–65, 1989.
  • Nilsson A, Ohlsson C, Isaksson OG, Lindahl A, Isgaard J: Hormonal regulation of longitudinal bone growth. Eur J Clin Nutr 48: S150–S160, 1994.
  • Chow J, Tobias JH, Colston KW, Chambers TJ: Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89: 74–78, 1992.
  • Raisz LO: Recent advances in bone cell biology: Interactions of vitamin D with other local and systemic factors. J Bone Miner Res 9: 191–197, 1990.
  • Kream BE, Petersen DN, Raisz LG: Parathyroid hormone blocks the stimulatory effect of insulin-like growth factor-I on collagen synthesis in cultured 21-day fetal rat calvariae. Bone 11: 411–415, 1990.
  • Klaushofer K, Hoffmann O, Gleispach H, Leis H-J, Czerwenka E, Koller K, Peterlik M: Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 4: 305–312, 1989.
  • Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112: 352–364, 1990.
  • Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF Jr, Lodish HF, Goldring SR: Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254: 1022–1024, 1991.
  • Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H: Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 50: 169–172, 1994.
  • Marks SC, Miller SC: Prostaglandins and the skeleton: the legacy and challenges of two decades of research. Endocrine J 1: 337–344, 1993.
  • Canalis E, Centrella M, McCarthy TL: Regulation of the insulin-like growth factor-II production in bone cultures. Endocrinology 129: 2457–2462, 1991.
  • Mohan S, Baylink DJ: Bone growth factors. Clin Orthop 263: 30–48, 1991.
  • McCarthy TL, Centrella M, Raisz LG, Canalis E: Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 128: 2895–2900, 1991.
  • Norrdin RW, Jee WS, High WB: The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids 41: 139–149, 1990.
  • Parodi PW: Cows’ milk fat components as possible anticarcinogenic agents. J Nutr 127: 1055–1060, 1997.
  • Ip C: Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am J Clin Nutr 66: 1523S–1529S, 1997.
  • Ip C, Jiang C, Thompson HJ, Scimeca JA: Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis 18: 755–759, 1997.
  • Cunningham DC, Harrison LY, Schultz TD: Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 17: 197–204, 1997.
  • Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D: Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res 17: 969–974, 1997.
  • Sehat N, Yurawecz MP, Roach JAG, Mossoba MM, Kramer JKG, Ku Y: Silver-ion high-performance liquid chromatographic separation and identification of conjugated linoleic acid isomers. Lipids 33: 217–221, 1998.
  • Kramer JKG, Parodi PW, Jensen RG, Mossoba MM, Yurawecz MP, Adlof RO: Rumenic acid: A proposed common name for the major conjugated linoleic acid isomer found in natural products. Lipids 33: 835, 1998.
  • Ha YL, Storkson J, Pariza MW: Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50: 1097–1101, 1990.
  • Cornell KK, Waters DJ, Coffman KT, Robinson JP, Watkins BA: Conjugated linoleic acid inhibited the in vitro proliferation of canine prostate cancer cells. FASEB 11: A579 (Abstract), 1997.
  • Li Y, Watkins BA: Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 33: 417–425, 1998.
  • Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KDG, Watkins BA: Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 14: 1153–1162, 1999.
  • Turek JJ, Li Y, Schoenlein IA, Allen KGD, Watkins BA: Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J Nutr Biochem 9: 258–266, 1998.
  • Sugano M, Tsujita A, Yamasaki M, Yamada K, Ikeda I, Kritchevsky D: Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem 8: 38–43, 1997.
  • Sugano M, Tsujita A, Yamasaki M, Noguchi M, Yamada K: Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33: 521–527, 1998.
  • Wuthier RE: Involvement of cellular metabolism of calcium and phosphate in calcification of avian growth plate cartilage. J Nutr 121: 301–309, 1993.
  • Gunnes M, Lehmann EH: Dietary calcium, saturated fat, fiber and vitamin C as predictors of forearm cortical and trabecular bone mineral density in healthy children and adolescents. Act Paediatr 84: 388–392, 1995.
  • Watkins BA, Shen C-L, Allen KGD, Seifert MF: Dietary (n-3) and (n-6) polyunsaturates and acetylsalicylic acid alter ex vivo PGE2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11: 1321–1332, 1996.
  • Watkins BA, Shen C-L, McMurtry JP, Xu H, Bain SD, Allen KGD, Seifert MF: Dietary lipids modulate bone prostaglandin E2 production, insulin-like growth factor-I concentration and formation rate in chicks. J Nutr 127: 1084–1091, 1997.
  • Hodgson JM, Wahlqvist ML, Boxall JA, Balazs ND: Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr 58: 228–234, 1993.
  • Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL: Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 54: 701–706, 1991.
  • Watkins BA: Regulatory effects of polyunsaturates on bone modeling and cartilage function. World Rev Nutr Dietetics 83: 38–51, 1998.
  • McCarthy TL, Ji C, Casinghino S, Centrella M: Alternate signaling pathways selectively regulate binding of insulin-like growth factor I and II on fetal rat bone cells. J Cell Biochem 68: 446–456, 1998.
  • Xu H, Watkins BA, Adkisson HD: Dietary lipids modify the fatty acid composition of cartilage, isolated chondrocytes and matrix vesicles. Lipids 29: 619–625, 1994.
  • Xu H, Watkins BA, Seifert MF: Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif Tissue Int 57: 293–300, 1995.
  • Watkins BA, Xu H, Turek JJ: Linoleate impairs collagen synthesis in primary cultures of avian chondrocytes. Proc Soc Exp Biol Med 212: 153–159, 1996.
  • Adkisson HD, Risener FS, Zarrinkar PP, Walla MD, Christie WW, Wuthier RE: Unique fatty acid composition of normal cartilage: discovery of high n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. FASEB J 5: 344–353, 1991.
  • Seifert MF, Watkins BA: Role of dietary lipid and antioxidants in bone metabolism. Nutr Res 17: 1209–1228, 1997.
  • Watkins BA, Seifert MF, Allen KGD: Importance of dietary fat in modulating PGE2 responses and influence of vitamin E on bone morphometry. World Rev Nutr Diet 82: 250–259, 1997.
  • Chen Y: “Modulatory Aspects of Polyunsaturated Fatty Acids on Epiphyseal Chondrocyte Function.” [MS Thesis.] West Lafayette, IN: Purdue University, 1997.
  • Ip C, Briggs SP, Haegele AD, Thompson HJ, Storkson J, Scimeca JA: The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis 17: 1045–1050, 1996.
  • Maciel FMB, Sarrazin P, Morisset S, Lora M, Patry C, Dumais R, Debrumfernandes AJ: Induction of cyclooxygenase-2 by parathyroid hormone in human osteoblasts in culture. J Rheumatol 24: 2429–2435, 1997.
  • Suda M, Tanaka K, Yasoda A, Natsui K, Sakuma Y, Tanaka I, Ushikubi F, Narumiya S, Nakao K: Prostaglandin E2 (PGE2) autoamplifies its production through EP 1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif Tissue Int 62: 327–331, 1998.
  • Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao SP, Khwaja S, Tahan SR, Dannenberg AJ: Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor-alpha and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26: 1538–1545, 1997.
  • Singh J, Hamid R, Reddy BS: Dietary fat and colon cancer - modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57: 3465–3470, 1997.
  • Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J: Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22: 309–316, 1998.
  • Ono K, Akatsu T, Murakami T, Nishikawa M, Yamamoto M, Kugai N, Motoyoshi K, Nagata N: Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. J Endocrinol 158: R1–R5, 1998.
  • Prunzanski W, Stefanski E, Vadas P, Kennedy BP, van den Bosch H: Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factor. Biochim Biophys Acta 1403: 47–56, 1998.
  • Sebedio JL, Juaneda P, Dobson G, Ramilison I, Martin JC, Chardigny JM, Christie WW: Metabolites of conjugated isomers of linoleic acid (CLA) in the rat. Biochim Biophys Acta 1345: 5–10, 1997.
  • Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305–315, 1990.
  • Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli LV, Peck WA: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86: 2398–2402, 1989.
  • Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC: 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89: 883–891, 1992.
  • Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, Bonewald LF: Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11: 1619–1627, 1996.
  • Kremer JM: Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 31: S243–S247, 1996.
  • Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J: Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 37: 824–829, 1994.
  • Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL: Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 7: 256–263, 1996.
  • Rose DP: Dietary fatty acids and prevention of hormone-responsive cancer. Proc Soc Exp Biol Med 216: 224–233, 1997.
  • Marks F, Furstenberger G, Muller-Decker K: Arachidonic acid metabolism as a reporter of skin irritancy and target of cancer chemoprevention. Toxicol Lett 96–97: 111–118, 1998.
  • Orr FW, Kostenuik P, Sanchez-Sweatman OH, Singh G: Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res Treat 25: 151–163, 1993.
  • Hamilton LC, Mitchell JA, Tomlinson AM, Warner TD: Synergy between cyclooxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal anti-inflammatory drug efficacy. FASEB J 13: 245–251, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.